Navigation Links
Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th
Date:11/6/2009

Email: robert.flamm@russopartnersllc.com www.russopartnersllc.com Media Relations Ian Stone Russo Partners LLC Tel: (619) 814-3510 Fax: (619) 955-5318 Email: ian.stone@russopartnersllc.com

This News Release contains certain forward-looking statements and information (collectively, "forward-looking statements") regarding the Company's planned presentation at Merriman Curhan Ford's 6th annual Investor Summit and the Company's research and development initiatives, which statements can be identified by the use of forward looking terminology such as "will", "developing", "November 10, 2009", or comparable forward-looking terminology. Helix's actual results could differ materially from those anticipated in these forward-looking statements as a result of numerous factors, including without limitation, the fact that the presentation and the posting of the slide show portion of the presentation on the Company's website are subject to change or cancellation without notice; Helix's need for additional future capital, which may not be available in a timely manner or at all; the need for additional research and development, the outcome of which is uncertain; and uncertainty whether L-DOS47 or Topical Interferon Alpha-2b, or any other product development initiatives, will be successfully developed or commercialized. See the Company's latest Form 20-F and other reports filed from time to time on SEDAR at www.sedar.com, and on EDGAR at www.sec.gov/edgar.shtml for a further description of certain of these and other important risks and uncertainties affecting the Company which could cause actual results to vary materially
'/>"/>

SOURCE Helix BioPharma Corp.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. AlphaHelix Presents AmpXpress(TM) at the BIOTECHNICA Show
2. Helix BioPharma Closes Private Placement
3. Helix BioPharma Announces $13.5 Million Private Placement
4. Helix Biopharma to Present at the Rodman & Renshaw 11th Annual Healthcare Conference
5. Double Helix Strengthens its Strategic Pricing and Reimbursement Practice with Hire of Caryn Zieses
6. New and Updated Online Tutorials for dbGaP, GAD, and DGV from OpenHelix
7. Helix BioPharma to Present L-DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference
8. Helix BioPharma Announces Q3 2009 Financial Results and Provides Product Development Update
9. Helix BioPharma to Present at the BioFinance 2009 Conference
10. Double Helix Appoints Ann Stuchiner Vice President of US Consulting Division
11. Helix BioPharma Announces Q2 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2013)... Dennis R. HIll M.D. Radiation Oncologist at the ... recently there has been a promotion of the idea that ... seed, or low dose rate, brachytherapy for prostate cancer. The ... a shorter half life, and gives a higher biologically effective ... has a higher average energy than the other commonly used ...
(Date:5/24/2013)... and TEL AVIV, Israel , May ... the "Company") (NYSE MKT: NSPR), a leader in embolic protection ... Company,s President and Chief Executive Officer, and Craig ... in the Benchmark Company, LLC One-on-One Investor Conference on Thursday ... Ave., Milwaukee, WI. The ...
(Date:5/24/2013)... OK (PRWEB) May 24, 2013 The ... casualties. And following its ravage, the mayor of Moore, one ... for new houses, said a report from cnn.com. Reaching out ... tornado victims complimentary Molderizer and Safe Shield to counter the ... the report published on May 22, 2013, caused 24 deaths, ...
(Date:5/23/2013)... their baby stopped breathing, his collapsed bronchus blocking the ... Bryan Gionfriddo watched helplessly, just praying that somehow the ... said he had a good chance of not leaving ... 20-month-old son, Kaiba. "At that point, we were desperate. ... run with it." , They found hope at the ...
Breaking Biology Technology:Dennis R. Hill MD HDR Prostate Brachytherapy Specialist Compares Prostate Cancer Treatment Options: Not All Low Dose Rate Brachytherapy Isotopes Are the Same 2Dennis R. Hill MD HDR Prostate Brachytherapy Specialist Compares Prostate Cancer Treatment Options: Not All Low Dose Rate Brachytherapy Isotopes Are the Same 3InspireMD To Participate In Benchmark Investor Conference On May 30th 2InspireMD To Participate In Benchmark Investor Conference On May 30th 3InspireMD To Participate In Benchmark Investor Conference On May 30th 4Mayor of Oklahoma-Tornado-Impaired Town Proposes Storm Shelter Bill, My Cleaning Products Offers Complimentary Molderizer and Safe Shield to Help Victim with Looming Mold 2Baby's life saved with groundbreaking 3-D printed device that restored his breathing 2Baby's life saved with groundbreaking 3-D printed device that restored his breathing 3
... Oct. 27 /Xinhua-PRNewswire/ -- Recently, China Green,Material ... Intellectual,Property Office for two patents for Industrialized ... and Industrialized Production,Method of Fully Biodegradable Edible ... applications have both obtained acceptance numbers,200810064592 and ...
... Trubion Pharmaceuticals Inc.,(Nasdaq: TRBN ) today ... study,demonstrating that repeat administration with TRU-015 continues ... rheumatoid arthritis,(RA) signs and symptoms based on ... announced positive results following preliminary,analyses from a ...
... Inc. ("Carna"),announced on October 27, 2008, the signing ... ("SUBC"). Under the terms of this,Agreement, SUBC will ... China., With China,s emergence as a strong ... companies have now established,research and production facilities in ...
Cached Biology Technology:Patent Technologies Keep CGMT in a Leading Position in the Industry 2Trubion Reports Re-treatment Results Following Phase 1/2a and Phase 2b Studies Evaluating TRU-015 for Rheumatoid Arthritis 2Trubion Reports Re-treatment Results Following Phase 1/2a and Phase 2b Studies Evaluating TRU-015 for Rheumatoid Arthritis 3Trubion Reports Re-treatment Results Following Phase 1/2a and Phase 2b Studies Evaluating TRU-015 for Rheumatoid Arthritis 4Trubion Reports Re-treatment Results Following Phase 1/2a and Phase 2b Studies Evaluating TRU-015 for Rheumatoid Arthritis 5Carna Biosciences Signs Distribution Agreement with Shanghai Universal Biotech Company 2
(Date:5/23/2013)... In an age when microbial pathogens are growing ... down infection, a team of Wisconsin scientists has synthesized ... the bacteria that cause staph infections. , Writing online ... , a group led by University of Wisconsin-Madison chemistry ... the "quorum sensing" behavior of Staphylococcus aureus , ...
(Date:5/22/2013)... join together in a major new effort to educate ... providing Earth,s people with clean water that looms ahead ... comment article in the current edition of Chemical ... American Chemical Society (ACS), the world,s largest scientific society. ... and Jerald L. Schnoor, Ph.D., explain that shortages of ...
(Date:5/22/2013)... feared Legionella pneumophila bacteria is responsible for ... In order to infect us, this pathogen has developed ... go unnoticed in our cells, thus avoiding these acting ... Basque biosciences research centre, CIC bioGUNE, in which teams ... USA and the National Supercomputation Centre in Barcelona (BSC) ...
Breaking Biology News(10 mins):University of Wisconsin chemists find new compounds to curb staph infection 2Mechanism discovered which aids Legionella to camouflage itself in the organism 2
... these larvae of tiger salamanders used as live bait ... hope to catch largemouth bass, channel catfish and other ... than they bargained for: salamanders in bait shops in ... and those in Arizona, with a chytrid fungus called ...
... BIO-key International,s MobileCop(R) and DaProSystems, Public Safety System ... a Link to DispatchersWALL, N.J., April 6 ... BKYI), a leader in finger-based biometric identification and ... of Roanoke, Virginia, a leading provider of Public ...
... Drilling Program (IODP), the world,s largest ocean research ... scientific support by welcoming Australia, India, and New ... New Zealand,s membership is agreed upon in a ... Lead Agencies: Japan,s Ministry of Education, Culture, Sports, ...
Cached Biology News:Spring fishing season arrives... and with it, amphibian diseases 2Spring fishing season arrives... and with it, amphibian diseases 3Nine Additional Virginia Law Enforcement Agencies Deploy BIO-key(R) and DaPro Systems Solution 2Nine Additional Virginia Law Enforcement Agencies Deploy BIO-key(R) and DaPro Systems Solution 3Nine Additional Virginia Law Enforcement Agencies Deploy BIO-key(R) and DaPro Systems Solution 4Australia, India, New Zealand join integrated ocean drilling program 2
... C-terminal end of the mouse retinoic acid receptor beta (RAR*). The ... RAR*. The sequence of PEP-005 is (amino to carboxy terminus): C ... - S - V - E - N - S - G ... - L - Q (The N-terminal cysteine has been added to ...
... potential applications for the use of small ... expression via the RNA interference (RNAi) pathway ... and molecular biology fields. siRNA for experimental ... chemically or enzymatically, and then transfected into ...
... automated hybridization system for the processing of ... hybridization and post hybridization washing of microarrays ... can process up to 12 slides at ... software, enabling the user to run all ...
... biological data hidden in your samples with eArray ... you to create your own microarray designs that ... own pace and receive delivery of your arrays ... a secure, online array creation application tool that ...
Biology Products: